Whole proteome analysis of LN18 cell treated with one of five DNA-damaging treatments (fractionated irradiation (IRM), temozolomide (TMZ), acute irradiation 24 hours (IRS 24h), acute irradiation 48 hours (IRS 48h) or doxorubicin (Dox)) +/- the BCL6 inhibitor FX1.
[doi:10.25345/C57W6796R]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: Glioblastoma ; BCL6 ; Irradiation ; Temozolomide ; Doxorubicin ; Whole proteome
Principal Investigators: (in alphabetical order) |
Melanie McConnell, VUW, New Zealand Paul Teesdale-Spittle, VUW, New Zealand |
Submitting User: | tribean |
Number of Files: | |
Total Size: | |
Spectra: | |
Subscribers: | |
Owner | Reanalyses | |
---|---|---|
Experimental Design | ||
Conditions:
|
||
Biological Replicates:
|
||
Technical Replicates:
|
||
Identification Results | ||
Proteins (Human, Remapped):
|
||
Proteins (Reported):
|
||
Peptides:
|
||
Variant Peptides:
|
||
PSMs:
|
||
Quantification Results | ||
Differential Proteins:
|
||
Quantified Proteins:
|
||
Browse Dataset Files | Browse Results |
FTP Download Link (click to copy):
|